{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-013170","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2022-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.942833+00:00","generated_at":"2026-06-24T00:59:00.664298+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"HOOKIPA Q2 2022 revenue $2.7M, net loss $16.4M; FDA accepts IND for HB-300, HB-200 Phase 2 underway","bullets":["Revenue $2.7M, down from $5.4M YoY due to lower cost reimbursements from Gilead collaboration.","Net loss $16.4M versus $17.2M in Q2 2021; R&D expenses decreased to $16.1M from $19.6M.","Cash, equivalents and restricted cash $118.9M at June 30, 2022, up from $66.9M at Dec 31, 2021.","FDA accepted IND for HB-300 (metastatic castration-resistant prostate cancer) and Drug Master File for platform.","HB-200 Phase 1 met all endpoints; Phase 2 started; initial data with pembrolizumab expected H2 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-013170","json":"https://secwatch.observer/filing/0001558370-22-013170.json","markdown":"https://secwatch.observer/filing/0001558370-22-013170.md","text":"https://secwatch.observer/filing/0001558370-22-013170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000155837022013170/0001558370-22-013170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000155837022013170/hook-20220811x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T00:59:00.664298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}